R1 uses Palantir AI to tackle some of the toughest challenges in healthcare reimbursement – so providers get paid for the care they provide to patients.

Close Top Banner

Dan Bise

EVP, Corporate Development and Strategy

Dan is Executive Vice President of Corporate Development and Strategy, responsible for enterprise-wide strategic initiatives and M&A.

Prior to joining R1 in 2025, Dan was a partner at the private equity firm Tailwind Capital, where he led investments in healthcare and tech-enabled services companies. Previously, Dan was head of corporate development and strategic partnerships at Change Healthcare, a healthcare technology company with more than $3 billion in revenue across providers, payers and pharmacies. In this role, Dan was responsible for more than a dozen strategic acquisitions, investments and partnerships, several of which focused on revenue cycle technology. He was extensively involved in the company’s 2017 merger with McKesson Technology Solutions and subsequent 2019 IPO, which valued the business at nearly $10 billion. He began his career as a private equity investor, including roles at Harvest Partners and BlackRock Private Equity Partners. Dan earned a Bachelor of Business Administration in finance and accounting from James Madison University and is a Chartered Financial Analyst.